Margareta Reis
1 – 17 of 17
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- Impact of generic substitution on levetiracetam serum concentration : A prospective study in an outpatient setting
- 2016
- Ongoing Pharmacological Management of Chronic Pain in Pregnancy
- Antipsychotics - Postmortem fatal and non-fatal reference concentrations
- 2015
- Use of tramadol in early pregnancy and congenital malformation risk.
- 2014
- Adverse drug reactions differ between CYP2D6 intermediate and extensive metabolizers in patients treated with antidepressive drugs
- 2013
- The Use of Central Nervous System Active Drugs During Pregnancy.
- 2012
- Neonatal Complications After Maternal Concomitant Use of SSRI and Other Central Nervous System Active Drugs During the Second or Third Trimester of Pregnancy.
- 2008
- Maternal Use of Antipsychotics in Early Pregnancy and Delivery Outcome.
- 2007
- Therapeutic drug monitoring of escitalopram in an outpatient setting
- 2005
- Inter- and intraindividual pharmacokinetic variations of mirtazapine and its N-demethyl metabolite in patients treated for major depressive disorder - A 6-month therapeutic drug monitoring study
- 2004
- Serum disposition of sertraline, N-desmethylsertraline and paroxetine: A pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression
- Compliance with SSRI medication during 6 months of treatment for major depression: an evaluation by determination of repeated serum drug concentrations
- 2003
- Therapeutic Drug Monitoring of Racemic Citalopram: A 5-Year Experience in Sweden, 1992-1997.
- 2002
- Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting.
- Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting
- Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting
- 1999
- Guidelines for follow-up of women at high risk for inherited breast cancer : consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer